Trial intelligence / Profile preview

Recormon for Anemia in Lymphoma and Myeloma

NCT02608060Phase 4Terminated

Sponsor
Roche
Start
Sep 2006
Primary completion
Oct 2007
Modality
Erythropoietins, Colony Stimulating Factors
Countries
1
01

Overview

A Phase 4 trial of epoetin beta in anemia, sponsored by Roche. Started Sep 2006; status: terminated.

02

Drugs

epoetin beta
03

Conditions

anemia

Beyond the preview

Go deeper on NCT02608060.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02608060.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call